Search Results - "Galamaga, Robert"

Durable and dramatic response to checkpoint inhibition combined with COX‐2 inhibitor celecoxib in a patient with p16+ metastatic sinonasal undifferentiated carcinoma: A case study by Trinh, Jonathan Q., Acosta, Cassaundra, Easwar, Arti, Galamaga, Robert, Tan, Alan

“…Background Sinonasal undifferentiated carcinoma (SNUC) is an exceedingly rare head and neck malignancy. No consensus exists on treatment for metastatic…”
Get full text

Avatrombopag for the treatment of patients with chemotherapy-induced thrombocytopenia: A case series by Galamaga, Robert, Johnston, Stephanie, Acosta, Cassaundra

“…Management of chemotherapy-induced thrombocytopenia (CIT) is challenging, often resulting in chemotherapy treatment delays, dose reduction, and treatment…”
Get full text

Aromatherapy Positively Affects Mood, Eeg Patterns of Alertness and Math Computations by Diego, Miguel A., Jones, Nancy Aaron, Field, Tiffany, Hernandez-reif, Maria, Schanberg, Saul, Kuhn, Cynthia, Galamaga, Mary, McAdam, Virginia, Galamaga, Robert

“…EEG activity, alertness, and mood were assessed in 40 adults given 3 minutes of aromatherapy using two aromas, lavender (considered a relaxing odor) or…”
Get full text

Safety and Efficacy of Nivolumab in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study by Vogelzang, Nicholas J., Olsen, Mark R., McFarlane, Joshua J., Arrowsmith, Edward, Bauer, Todd M., Jain, Rohit K., Somer, Bradley, Lam, Elaine T., Kochenderfer, Mark D., Molina, Ana, Doshi, Gurjyot, Lingerfelt, Brian, Hauke, Ralph J., Gunuganti, Vijay, Schnadig, Ian, Van Veldhuizen, Peter, Fleming, Mark, Galamaga, Robert, Gupta, Mukul, Hool, Hugo, Hutson, Thomas, Zhang, Joshua, McHenry, M. Brent, Johansen, Jennifer L., Tykodi, Scott S.

“…The open-label phase IIIb/IV CheckMate 374 study (NCT02596035) was conducted to validate the safety and efficacy of flat-dose nivolumab 240 mg every 2 weeks…”
Get full text

Factors predicting survival in peripheral T‐cell lymphoma in the USA: a population‐based analysis of 8802 patients in the modern era by Petrich, Adam M., Helenowski, Irene B., Bryan, Locke J., Rozell, Shaina A., Galamaga, Robert, Nabhan, Chadi

“…Summary Current prognostic models for peripheral T‐cell lymphoma (PTCL) have multiple limitations, and questions exist regarding applicability to current…”
Get full text

Trends in Incidence and Outcome in T-Cell Lymphoma Since 1992: A SEER Database Analysis by Petrich, Adam M., Helenowski, Irene, Galamaga, Robert W., Nabhan, Chadi

“…Abstract 4264 Recent reports have suggested an increase in the incidence of T-cell lymphoma (TCL) in the United States. Despite newer therapies, however, it…”
Get full text

Significance of chromosome 17 polysomy in breast cancer by Galamaga, Robert W., Mariani, Rachel, Almanaseer, Imad, Bitran, Jacob D.

“…Abstract only e12002 Background: Human epidermal growth factor receptor 2 (HER-2) overexpression occurs in up to 30% of breast cancers and has been associated…”
Get full text